6Cheng CY, Chen GH, Chang CS, et al. Sclerotherapy on liver cirrhosis with esophageal variceal bleeding, eight years of experi ence. Zhonghua Yi Xue ZaZhi (Taipei), 1994, 54:321-328.
7Hashizume M, Kitano S, Koyanagi N, et al. Endoscopic injection sclerotherapy for 1 000 patients with esophageal varices: a nine year prospective study. Hepatology, 1992, 15;69-75.
8Tomikawa M, Hashizume M, Okita K, et al. Endoscopic injection sclerotherapy in the management of 2105 patients with esophageal varices. Surgery, 2002. 1:31 (1 Suppl) : S171-S175.
9Cheng L, Wang Z, Li C, et al. Experience in sclerotherapy for esophagogastric variceal bleeding. Chin Med J (Engl), 2002, 115:919-922.
10Lo GH. Lai KH, Cheng JS. el al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology, 2000, 32:461-465.
6Sarin SK, Sharma P. Terlipressin: an asset for hepatologists. Hepatology, 2011,54 : 724-728.
7Appenrodt B, Trebicka J, Sauerbruch T. Complications of liver cirrhosis. DtschMedWochenschr,2011,136:1601-1604.
8LAY C S, TSAI Y T, LEE F Y, et al. Endoscopivariceal ligation versus propranolol in prophylaxis offirst variceal bleed- ing in patients with cirrhosis[J]. JGastroenterol Hepatol, 2006, 21 : 413 -419.
9BENDTSEN F, KRAG A, MLLER S. Treatment of acute variceal bleeding[J]. Dig Liver Dis, 2008, 40:328 -336.
10D'AMICO G, PIETROSI G, TARANTINO I, et al. Emergen- cy sclerotherapy versus vasoactive drugs for varicesal bleeding in cirrhosis a Cochrane meta - analysis [ J]. Gastroenterolo- gy, 2003, 124(5): 1277-1291.
